Nevro Corp. was the subject of a Schedule 13G/A filed by Beryl Capital entities and David A. Witkin reporting that none of the reporting persons beneficially own shares of Nevro common stock. The filing lists Beryl Capital Management LLC, Beryl Capital Management LP, Beryl Capital Partners II LP and David A. Witkin as reporting persons, states their organizational relationships, and includes a disclaimer that they do not claim beneficial ownership except for any pecuniary interest. The statement shows 0 shares beneficially owned and 0% of the class, with all voting and dispositive powers reported as zero, indicating no current economic or voting stake disclosed in this filing.
The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC jointly reported beneficial ownership of 1,172 shares of Nevro Corp. common stock, representing 0.0% of the class. The filing shows shared voting power of 905 shares and shared dispositive power of 1,172 shares, with no sole voting or dispositive power recorded.
The Schedule 13G/A states these holdings are reported as held in the ordinary course of business and not for the purpose of influencing control. The filing also discloses that Goldman Sachs & Co. LLC is a subsidiary of The Goldman Sachs Group, Inc., and the parties executed a joint filing agreement documenting the joint submission.